68.00
price down icon1.23%   -0.85
after-market After Hours: 68.00
loading
Ventas Inc stock is traded at $68.00, with a volume of 2.07M. It is down -1.23% in the last 24 hours and down -0.12% over the past month. Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$68.85
Open:
$68.72
24h Volume:
2.07M
Relative Volume:
0.75
Market Cap:
$30.90B
Revenue:
$5.30B
Net Income/Loss:
$199.54M
P/E Ratio:
157.23
EPS:
0.4325
Net Cash Flow:
$1.24B
1W Performance:
-3.30%
1M Performance:
-0.12%
6M Performance:
+7.36%
1Y Performance:
+9.01%
1-Day Range:
Value
$67.75
$68.72
1-Week Range:
Value
$67.75
$70.49
52-Week Range:
Value
$56.68
$71.36

Ventas Inc Stock (VTR) Company Profile

Name
Name
Ventas Inc
Name
Phone
(312) 660-3800
Name
Address
300 N LASALLE STREET, CHICAGO, IL
Name
Employee
498
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
VTR's Discussions on Twitter

Compare VTR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
REIT - Healthcare Facilities icon
VTR
Ventas Inc
68.00 31.29B 5.30B 199.54M 1.24B 0.4325
REIT - Healthcare Facilities icon
WELL
Welltower Inc
169.14 115.71B 9.27B 1.14B 1.60B 1.2106
REIT - Healthcare Facilities icon
DOC
Healthpeak Properties Inc
18.85 13.30B 2.80B 279.29M 1.20B 0.40
REIT - Healthcare Facilities icon
CTRE
Caretrust Reit Inc
33.99 7.70B 219.54M 99.24M 205.68M 0.72
REIT - Healthcare Facilities icon
AHR
American Healthcare Reit Inc
40.18 6.92B 2.07B -37.81M 84.15M -0.27

Ventas Inc Stock (VTR) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-01-25 Initiated Cantor Fitzgerald Overweight
Sep-19-25 Initiated UBS Neutral
Jun-23-25 Upgrade JP Morgan Neutral → Overweight
Mar-07-25 Upgrade Argus Hold → Buy
Jan-17-25 Upgrade Robert W. Baird Neutral → Outperform
Oct-01-24 Upgrade Wells Fargo Equal Weight → Overweight
Mar-18-24 Upgrade Evercore ISI In-line → Outperform
Feb-26-24 Downgrade Wells Fargo Overweight → Equal Weight
Jan-30-24 Initiated Deutsche Bank Buy
Jan-16-24 Upgrade BofA Securities Neutral → Buy
Nov-07-23 Upgrade Wedbush Neutral → Outperform
Oct-11-23 Initiated Exane BNP Paribas Outperform
Oct-03-23 Initiated Wedbush Neutral
Sep-20-23 Downgrade Raymond James Strong Buy → Outperform
Aug-11-23 Downgrade BofA Securities Buy → Neutral
Jun-23-23 Upgrade Raymond James Outperform → Strong Buy
Apr-20-23 Initiated Wells Fargo Overweight
Nov-01-22 Reiterated Credit Suisse Outperform
Nov-01-22 Downgrade Raymond James Strong Buy → Outperform
Oct-10-22 Downgrade Robert W. Baird Outperform → Neutral
Jun-30-22 Upgrade Jefferies Hold → Buy
Jun-23-22 Initiated Credit Suisse Outperform
Jun-03-22 Initiated CapitalOne Overweight
May-18-22 Upgrade Credit Suisse Neutral → Outperform
Mar-11-22 Upgrade BMO Capital Markets Market Perform → Outperform
Mar-11-22 Upgrade BofA Securities Neutral → Buy
Feb-01-22 Initiated Credit Suisse Neutral
Jan-20-22 Upgrade Mizuho Neutral → Buy
Dec-14-21 Upgrade Citigroup Neutral → Buy
Nov-22-21 Downgrade SMBC Nikko Outperform → Neutral
Oct-04-21 Resumed Morgan Stanley Equal-Weight
Sep-23-21 Upgrade Raymond James Outperform → Strong Buy
Sep-07-21 Upgrade Deutsche Bank Hold → Buy
Aug-26-21 Upgrade BMO Capital Markets Underperform → Market Perform
Jul-14-21 Resumed Mizuho Neutral
Jun-15-21 Initiated Wolfe Research Outperform
Jun-11-21 Upgrade Barclays Equal Weight → Overweight
May-13-21 Upgrade KeyBanc Capital Markets Underweight → Overweight
May-13-21 Upgrade Robert W. Baird Neutral → Outperform
Jan-08-21 Downgrade BMO Capital Markets Market Perform → Underperform
Jan-06-21 Initiated Robert W. Baird Neutral
Nov-30-20 Upgrade BofA Securities Underperform → Buy
Nov-10-20 Upgrade Jefferies Underperform → Hold
Sep-08-20 Downgrade Argus Buy → Hold
Sep-02-20 Resumed Stifel Hold
Aug-20-20 Downgrade Raymond James Strong Buy → Outperform
Aug-14-20 Upgrade Evercore ISI Underperform → In-line
Aug-14-20 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jun-15-20 Downgrade Evercore ISI In-line → Underperform
Mar-25-20 Upgrade Raymond James Mkt Perform → Strong Buy
Mar-23-20 Downgrade BofA/Merrill Neutral → Underperform
Mar-10-20 Downgrade Jefferies Buy → Underperform
Feb-28-20 Upgrade Raymond James Underperform → Mkt Perform
Jan-22-20 Downgrade Raymond James Mkt Perform → Underperform
Jan-17-20 Upgrade Jefferies Hold → Buy
Dec-20-19 Resumed Mizuho Neutral
Dec-10-19 Downgrade Wells Fargo Market Perform → Underperform
Nov-19-19 Upgrade Argus Hold → Buy
Oct-30-19 Downgrade Stifel Buy → Hold
Oct-28-19 Downgrade CapitalOne Overweight → Equal Weight
Oct-28-19 Downgrade Citigroup Buy → Neutral
View All

Ventas Inc Stock (VTR) Latest News

pulisher
Oct 06, 2025

Ventas Announces Third Quarter 2025 Earnings Release Date and Conference Call - The Globe and Mail

Oct 06, 2025
pulisher
Oct 06, 2025

Will Ventas Inc. stock maintain strong growth2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Morningstar’s REIT Call Misses the Mark and the 8.4% Fund to Buy - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Robeco Institutional Asset Management B.V. Sells 92,517 Shares of Ventas, Inc. $VTR - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

Will Ventas Inc. (VEN) stock see valuation expansion2025 Price Targets & Weekly Stock Breakout Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why Ventas Inc. stock attracts HNW investorsEarnings Miss & Safe Swing Trade Setups - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What earnings margins imply for Ventas Inc. stockJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

OLD National Bancorp IN Has $13.29 Million Stock Holdings in Ventas, Inc. $VTR - MarketBeat

Oct 05, 2025
pulisher
Oct 05, 2025

How dovish Fed policy supports Ventas Inc. stockJuly 2025 Review & Accurate Intraday Trade Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Stock Yards Bank & Trust Co. Has $823,000 Position in Ventas, Inc. $VTR - MarketBeat

Oct 05, 2025
pulisher
Oct 05, 2025

Can Ventas Inc. stock surprise with quarterly resultsMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Real time scanner hits for Ventas Inc. explainedJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

J. Safra Sarasin Holding AG Invests $1.85 Million in Ventas, Inc. $VTR - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Vanderbilt University Increases Stock Position in Ventas, Inc. $VTR - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

U.S. Healthcare Real Estate Market is Going to Boom: Strategic - openPR.com

Oct 03, 2025
pulisher
Oct 03, 2025

What Ventas (VTR)'s Latest Dividend Declaration Reveals About Its Commitment to Shareholder Returns - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Is Ventas Inc. stock undervalued at current priceGap Up & Daily Oversold Bounce Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Ventas Inc. forming a reversal patternTrade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What does recent volatility data suggest for Ventas Inc.2025 Investor Takeaways & Growth Focused Stock Pick Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $77 - 富途牛牛

Oct 03, 2025
pulisher
Oct 02, 2025

Insider Sell Alert: Peter Bulgarelli Sells Shares of Ventas Inc (VTR) - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Ventas (NYSE:VTR) CEO Sells $142,779.60 in Stock - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Ventas (NYSE:VTR) CEO Debra Cafaro Sells 10,322 Shares - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Ventas (NYSE:VTR) Raised to "Strong-Buy" at Cantor Fitzgerald - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Cantor Fitzgerald Investment Advisors L.P. Increases Stock Position in Ventas, Inc. $VTR - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Ventas, Inc. $VTR Shares Purchased by USA Financial Formulas - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

UBS Initiates Coverage on Ventas (VTR) Citing SHOP Strength and AFFO Growth - Yahoo

Oct 02, 2025
pulisher
Oct 01, 2025

Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance

Oct 01, 2025
pulisher
Oct 01, 2025

Using economic indicators to assess Ventas Inc. potential2025 Earnings Surprises & Entry Point Strategy Guides - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Cantor Fitzgerald initiates Ventas stock with Overweight rating on senior housing growth - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

Lbp Am Sa Buys 172,113 Shares of Ventas, Inc. $VTR - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

Ventas sells Issaquah senior community for over $38M - DJC

Sep 30, 2025
pulisher
Sep 29, 2025

Ventas, Inc. Experiences Revision in Stock Evaluation Amid Positive Market Indicators - Markets Mojo

Sep 29, 2025
pulisher
Sep 29, 2025

News | Ventas secures $475 million CMBS loan on Pennsylvania life sciences buildings - CoStar

Sep 29, 2025
pulisher
Sep 29, 2025

Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit

Sep 29, 2025
pulisher
Sep 29, 2025

Does Ventas' (VTR) Steady Dividend Reflect Strong Fundamentals or Limit Strategic Flexibility? - Yahoo Finance

Sep 29, 2025

Ventas Inc Stock (VTR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Ventas Inc Stock (VTR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
CAFARO DEBRA A
Chairman and CEO
Oct 01 '25
Sale
70.24
10,322
724,986
1,145,695
Bulgarelli Peter J.
EVP OM&R-Ventas/Pres&CEO-LHS
Oct 01 '25
Sale
70.26
2,554
179,435
116,488
Bulgarelli Peter J.
EVP OM&R-Ventas/Pres&CEO-LHS
Sep 30 '25
Sale
69.99
2,040
142,780
119,042
reit_healthcare_facilities DOC
$18.85
price down icon 1.52%
$33.99
price down icon 1.73%
reit_healthcare_facilities AHR
$40.18
price down icon 2.12%
reit_healthcare_facilities HR
$17.68
price down icon 1.56%
$17.98
price down icon 0.17%
Cap:     |  Volume (24h):